Jogl G., Tong L. Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport (англ.) // Cell : journal. — Cell Press, 2003. — January (vol. 112, no. 1). — P. 113—122. — doi:10.1016/S0092-8674(02)01228-X. — PMID12526798.
Wu D., Govindasamy L., Lian W., Gu Y., Kukar T., Agbandje-McKenna M., McKenna R. Structure of human carnitine acetyltransferase. Molecular basis for fatty acyl transfer (англ.) // The Journal of Biological Chemistry : journal. — 2003. — April (vol. 278, no. 15). — P. 13159—13165. — doi:10.1074/jbc.M212356200. — PMID12562770.
Cronin C.N. The conserved serine-threonine-serine motif of the carnitine acyltransferases is involved in carnitine binding and transition-state stabilization: a site-directed mutagenesis study (англ.) // Biochemical and Biophysical Research Communications : journal. — 1997. — September (vol. 238, no. 3). — P. 784—789. — doi:10.1006/bbrc.1997.7390. — PMID9325168.
Brunner S., Kramar K., Denhardt D.T., Hofbauer R. Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression (англ.) // The Biochemical Journal[англ.] : journal. — 1997. — March (vol. 322, no. 2). — P. 403—410. — doi:10.1042/bj3220403. — PMID9065756. — PMC1218205.
Giannessi F., Chiodi P., Marzi M., Minetti P., Pessotto P., De Angelis F., Tassoni E., Conti R., Giorgi F., Mabilia M., Dell'Uomo N., Muck S., Tinti M.O., Carminati P., Arduini A. Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 2001. — July (vol. 44, no. 15). — P. 2383—2386. — doi:10.1021/jm010889. — PMID11448219.
Jogl G., Tong L. Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport (англ.) // Cell : journal. — Cell Press, 2003. — January (vol. 112, no. 1). — P. 113—122. — doi:10.1016/S0092-8674(02)01228-X. — PMID12526798.
Wu D., Govindasamy L., Lian W., Gu Y., Kukar T., Agbandje-McKenna M., McKenna R. Structure of human carnitine acetyltransferase. Molecular basis for fatty acyl transfer (англ.) // The Journal of Biological Chemistry : journal. — 2003. — April (vol. 278, no. 15). — P. 13159—13165. — doi:10.1074/jbc.M212356200. — PMID12562770.
Cronin C.N. The conserved serine-threonine-serine motif of the carnitine acyltransferases is involved in carnitine binding and transition-state stabilization: a site-directed mutagenesis study (англ.) // Biochemical and Biophysical Research Communications : journal. — 1997. — September (vol. 238, no. 3). — P. 784—789. — doi:10.1006/bbrc.1997.7390. — PMID9325168.
Brunner S., Kramar K., Denhardt D.T., Hofbauer R. Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression (англ.) // The Biochemical Journal[англ.] : journal. — 1997. — March (vol. 322, no. 2). — P. 403—410. — doi:10.1042/bj3220403. — PMID9065756. — PMC1218205.
Anderson R.C. Carnitine palmitoyltransferase: a viable target for the treatment of NIDDM? (англ.) // Current Pharmaceutical Design[англ.] : journal. — 1998. — February (vol. 4, no. 1). — P. 1—16. — PMID10197030.
Giannessi F., Chiodi P., Marzi M., Minetti P., Pessotto P., De Angelis F., Tassoni E., Conti R., Giorgi F., Mabilia M., Dell'Uomo N., Muck S., Tinti M.O., Carminati P., Arduini A. Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 2001. — July (vol. 44, no. 15). — P. 2383—2386. — doi:10.1021/jm010889. — PMID11448219.
Brunner S., Kramar K., Denhardt D.T., Hofbauer R. Cloning and characterization of murine carnitine acetyltransferase: evidence for a requirement during cell cycle progression (англ.) // The Biochemical Journal[англ.] : journal. — 1997. — March (vol. 322, no. 2). — P. 403—410. — doi:10.1042/bj3220403. — PMID9065756. — PMC1218205.
Anderson R.C. Carnitine palmitoyltransferase: a viable target for the treatment of NIDDM? (англ.) // Current Pharmaceutical Design[англ.] : journal. — 1998. — February (vol. 4, no. 1). — P. 1—16. — PMID10197030.
Giannessi F., Chiodi P., Marzi M., Minetti P., Pessotto P., De Angelis F., Tassoni E., Conti R., Giorgi F., Mabilia M., Dell'Uomo N., Muck S., Tinti M.O., Carminati P., Arduini A. Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents (англ.) // Journal of Medicinal Chemistry[англ.] : journal. — 2001. — July (vol. 44, no. 15). — P. 2383—2386. — doi:10.1021/jm010889. — PMID11448219.